TriLink BioTechnologies, a Maravai LifeSciences company and provider of life science reagents and services, has partnered ...

TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...

Barclays analyst Luke Sergott raised the firm’s price target on Avantor (AVTR) to $26 from $25 and keeps an Overweight rating on the shares.

In a report released today, Luke Sergott from Barclays maintained a Buy rating on Avantor (AVTR – Research Report), with a price target of ...

Forsta AP Fonden raised its holdings in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 3.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities ...

Wall Street expects flat earnings compared to the year-ago quarter on lower revenues when Avantor, Inc. (AVTR) reports results for the quarter ended December 2024. While this widely-known consensus ...

Highlights,Nisa Investment Advisors LLC increased its stake in Avantor by 917.2% in the fourth quarter.,Market assessments ...

UBS has recently reduced Avantor Inc (AVTR) stock to Neutral rating, as announced on January 17, 2025, according to Finviz. Earlier, on August 28, 2024, Wells Fargo had initiated the stock to ...

Avantor Inc (AVTR) stock saw a modest uptick, ending the day at $22.06 which represents a slight increase of $0.19 or 0.87% from the prior close of $21.87. The stock opened at $21.96 and touched a low ...

Check the time stamp on this data. Updated AI-Generated Signals for Avantor Inc. (AVTR) available here: AVTR. Type a few symbols and Take a Trial. The signals for these will appear immediately on your ...

Elevance Health (ELV) delivered earnings and revenue surprises of 1.05% and 0.71%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Avantor (NYSE:AVTR – Get Free Report) had its price target lowered by Raymond James from $29.00 to $26.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The ...